Vanguard S&P Mid-Cap 400 Growth ETF (IVOG)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Vanguard S&P Mid-Cap 400 Growth ETF (IVOG) with AI Score 47/100 (Weak). Vanguard S&P Mid-Cap 400 Growth ETF (IVOG) aims to replicate the performance of the S&P MidCap 400 Growth Index. The ETF offers investors exposure to U. S. Market cap: 0, Sector: Financial services.
Last analyzed: Mar 16, 2026Vanguard S&P Mid-Cap 400 Growth ETF (IVOG) Financial Services Profile
Vanguard S&P Mid-Cap 400 Growth ETF (IVOG) provides targeted exposure to U.S. mid-cap growth stocks, mirroring the S&P MidCap 400 Growth Index. With a focus on long-term capital appreciation, IVOG offers a gauge of overall U.S. mid-cap growth stock returns, suitable for investors with long-term goals and a higher risk tolerance.
Investment Thesis
IVOG presents an investment opportunity for those seeking exposure to the U.S. mid-cap growth segment. The ETF's primary value driver is its ability to closely track the S&P MidCap 400 Growth Index, providing a benchmark for investors seeking to align their portfolios with mid-cap growth performance. A key growth catalyst for IVOG is the continued expansion of the mid-cap growth market, driven by innovation, economic growth, and evolving consumer preferences. The ETF's low expense ratio enhances its appeal, as it minimizes the impact of fees on overall returns. Potential risks include market volatility, economic downturns, and shifts in investor sentiment toward growth stocks. The ETF's performance is also subject to the performance of the underlying companies within the S&P MidCap 400 Growth Index. With a beta of 1.14, IVOG exhibits slightly higher volatility than the overall market, indicating a potential for both increased gains and losses.
Based on FMP financials and quantitative analysis
Key Highlights
- IVOG tracks the S&P MidCap 400 Growth Index, providing targeted exposure to U.S. mid-cap growth stocks.
- The ETF underwent a 2:1 share split on March 14, 2023, increasing the number of shares outstanding and decreasing the price per share.
- IVOG offers high potential for investment growth, with share value rising and falling more sharply than funds holding bonds.
- The ETF is designed for long-term investment goals where capital appreciation is essential.
- IVOG has a beta of 1.14, indicating slightly higher volatility than the overall market.
Competitors & Peers
Strengths
- Low expense ratio
- Tracks the S&P MidCap 400 Growth Index
- Exposure to U.S. mid-cap growth stocks
- Part of the Vanguard family of funds
Weaknesses
- No dividend payouts
- Share value fluctuates more sharply than funds holding bonds
- Performance is tied to the performance of the S&P MidCap 400 Growth Index
- Beta of 1.14 indicates higher volatility than the overall market
Catalysts
- Ongoing: Continued expansion of the mid-cap growth market, driven by innovation and economic growth.
- Ongoing: Increased adoption of ETFs as investors seek cost-effective investment solutions.
- Ongoing: Growing demand for growth stocks as investors seek higher returns.
- Upcoming: Potential for strategic partnerships and distribution channels to expand IVOG's reach.
- Upcoming: Launch of new ETFs targeting specific segments of the mid-cap growth market.
Risks
- Ongoing: Market volatility can impact IVOG's performance, leading to potential losses for investors.
- Potential: Economic downturns can negatively affect the performance of mid-cap growth stocks.
- Potential: Shifts in investor sentiment toward growth stocks can lead to decreased demand for IVOG.
- Ongoing: Competition from other ETFs and investment vehicles can impact IVOG's market share.
- Potential: Changes in the composition of the S&P MidCap 400 Growth Index can affect IVOG's performance.
Growth Opportunities
- Expansion of the Mid-Cap Growth Market: The mid-cap growth market is expected to expand as innovative companies emerge and disrupt traditional industries. This growth is driven by factors such as technological advancements, changing consumer preferences, and economic expansion. IVOG is positioned to benefit from this trend by providing investors with exposure to a diversified portfolio of mid-cap growth stocks. The market size for mid-cap growth stocks is estimated to reach trillions of dollars in the coming years, presenting a significant opportunity for IVOG to attract new investors and grow its assets under management. Timeline: Ongoing.
- Increased Adoption of ETFs: ETFs have gained popularity among investors due to their low cost, transparency, and liquidity. This trend is expected to continue as more investors seek cost-effective and efficient investment solutions. IVOG is well-positioned to capitalize on this trend by offering a low-cost ETF that tracks the S&P MidCap 400 Growth Index. The ETF market is projected to reach trillions of dollars in assets under management in the next few years, creating a favorable environment for IVOG's growth. Timeline: Ongoing.
- Growing Demand for Growth Stocks: Growth stocks have historically outperformed value stocks over the long term, attracting investors seeking higher returns. This trend is expected to persist as companies with strong growth potential continue to emerge and disrupt traditional industries. IVOG is designed to provide investors with exposure to a diversified portfolio of growth stocks, making it a noteworthy option for those seeking to capitalize on this trend. The demand for growth stocks is expected to remain strong in the coming years, driving growth in IVOG's assets under management. Timeline: Ongoing.
- Strategic Partnerships and Distribution Channels: IVOG can expand its reach by forming strategic partnerships with financial advisors, brokerage firms, and other distribution channels. These partnerships can help IVOG reach a wider audience of potential investors and increase its assets under management. By leveraging the expertise and networks of its partners, IVOG can effectively market its ETF and attract new investors. The development of new distribution channels can also enhance IVOG's accessibility and convenience for investors. Timeline: Ongoing.
- Product Innovation and Expansion: IVOG can enhance its product offerings by launching new ETFs that target specific segments of the mid-cap growth market. These new ETFs can cater to investors with different risk profiles and investment objectives. By expanding its product line, IVOG can attract a broader range of investors and increase its assets under management. Product innovation can also help IVOG differentiate itself from its competitors and maintain its competitive edge. Timeline: Ongoing.
Opportunities
- Expansion of the mid-cap growth market
- Increased adoption of ETFs
- Growing demand for growth stocks
- Strategic partnerships and distribution channels
Threats
- Market volatility
- Economic downturns
- Shifts in investor sentiment toward growth stocks
- Competition from other ETFs and investment vehicles
Competitive Advantages
- Low-Cost Structure: Vanguard is known for its low-cost investment options, providing IVOG with a competitive advantage.
- Index Tracking: IVOG's focus on tracking the S&P MidCap 400 Growth Index provides a benchmark for investors.
- Brand Reputation: Vanguard's established brand reputation enhances investor confidence.
About IVOG
The Vanguard S&P Mid-Cap 400 Growth ETF (IVOG) is designed to track the performance of the S&P MidCap 400 Growth Index, offering investors a focused approach to U.S. mid-cap growth stocks. The fund provides exposure to companies within the S&P 400 that exhibit growth characteristics. IVOG operates under the umbrella of Vanguard, a well-established investment management firm known for its low-cost investment options and commitment to investor-focused principles. The ETF's investment strategy centers on closely replicating the index's return, making it a tool for investors seeking to align their portfolios with the performance of mid-cap growth companies. IVOG is designed for investors with long-term investment horizons and a higher risk tolerance, as the value of its shares can fluctuate more sharply than funds holding bonds. The ETF underwent a 2:1 share split on March 14, 2023, which decreased the price per share while proportionately increasing the number of shares outstanding. This split aimed to enhance the ETF's accessibility to a broader range of investors. IVOG's investment portfolio reflects the composition of the S&P MidCap 400 Growth Index, encompassing a range of sectors and industries within the mid-cap market segment. The fund's performance is directly tied to the performance of these underlying growth stocks, making it a tool for participating in the potential upside of the mid-cap growth market. IVOG does not offer dividend payouts, emphasizing its focus on capital appreciation rather than income generation. The ETF's expense ratio is designed to be competitive, aligning with Vanguard's commitment to providing cost-effective investment solutions. IVOG's structure as an ETF provides intraday liquidity, allowing investors to buy and sell shares throughout the trading day. This feature enhances the fund's flexibility and accessibility for investors seeking to manage their positions in response to market conditions.
What They Do
- Invests in stocks in the S&P MidCap 400 Growth Index.
- Focuses on tracking the index’s return.
- Offers exposure to U.S. mid-cap growth stocks.
- Provides potential for investment growth.
- Share value rises and falls more sharply than that of funds holding bonds.
- Appropriate for long-term goals where money’s growth is essential.
Business Model
- IVOG generates revenue through management fees charged to investors.
- The ETF's expense ratio is designed to be competitive.
- Revenue is directly tied to the ETF's assets under management (AUM).
Industry Context
The asset management industry is characterized by a diverse range of investment vehicles, including ETFs, mutual funds, and hedge funds. IVOG operates within the ETF segment, specifically targeting the mid-cap growth market. The industry is influenced by market trends, economic conditions, and investor preferences. The competitive landscape includes both large and small asset management firms, each offering a variety of investment strategies and products. IVOG's focus on tracking the S&P MidCap 400 Growth Index positions it as a tool for investors seeking to align their portfolios with the performance of mid-cap growth companies.
Key Customers
- Individual investors seeking exposure to U.S. mid-cap growth stocks.
- Institutional investors looking to diversify their portfolios.
- Financial advisors seeking cost-effective investment solutions for their clients.
Financials
Chart & Info
Vanguard S&P Mid-Cap 400 Growth ETF (IVOG) stock price: Price data unavailable
Latest News
-
Vanguard S&P Mid-Cap 400 Growth ETF (NYSEARCA:IVOG) Short Interest Up 46.7% in January
defenseworld.net · Feb 1, 2026
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for IVOG.
Price Targets
Wall Street price target analysis for IVOG.
MoonshotScore
What does this score mean?
The MoonshotScore rates IVOG's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Vanguard S&P Mid-Cap 400 Growth ETF Stock: Key Questions Answered
What does Vanguard S&P Mid-Cap 400 Growth ETF do?
The Vanguard S&P Mid-Cap 400 Growth ETF (IVOG) aims to replicate the performance of the S&P MidCap 400 Growth Index, providing investors with exposure to a diversified portfolio of U.S. mid-cap growth stocks. The ETF invests in companies within the S&P 400 that exhibit growth characteristics, offering a gauge of overall U.S. mid-cap growth stock returns. IVOG is designed for investors with long-term investment horizons and a higher risk tolerance, as the value of its shares can fluctuate more sharply than funds holding bonds. The ETF does not offer dividend payouts, emphasizing its focus on capital appreciation rather than income generation.
What do analysts say about IVOG stock?
AI analysis is pending for IVOG, so current analyst consensus is unavailable. However, as an ETF tracking the S&P MidCap 400 Growth Index, IVOG's performance is closely tied to the performance of the underlying mid-cap growth stocks. Investors may want to evaluate factors such as market volatility, economic conditions, and investor sentiment toward growth stocks when evaluating IVOG. The ETF's low expense ratio and focus on tracking the index are key considerations for investors seeking cost-effective exposure to the mid-cap growth market. The ETF's beta of 1.14 indicates slightly higher volatility than the overall market.
What are the main risks for IVOG?
The main risks for IVOG include market volatility, economic downturns, and shifts in investor sentiment toward growth stocks. Market volatility can impact IVOG's performance, leading to potential losses for investors. Economic downturns can negatively affect the performance of mid-cap growth stocks, impacting IVOG's returns. Shifts in investor sentiment toward growth stocks can lead to decreased demand for IVOG. Competition from other ETFs and investment vehicles can also impact IVOG's market share. Changes in the composition of the S&P MidCap 400 Growth Index can affect IVOG's performance.
How is Vanguard S&P Mid-Cap 400 Growth ETF adapting to fintech disruption?
As an ETF, Vanguard S&P Mid-Cap 400 Growth ETF doesn't directly adapt to fintech disruption in the same way that an individual financial services company would. However, the companies within the S&P MidCap 400 Growth Index are subject to fintech disruption. IVOG's performance will reflect the aggregate success or failure of its constituent companies in navigating this disruption. Vanguard, as the ETF provider, continually assesses the composition of the index and makes adjustments as necessary to ensure that the ETF remains aligned with its investment objective. This includes monitoring the impact of fintech on the underlying companies and making adjustments to the index as needed.
How does Vanguard S&P Mid-Cap 400 Growth ETF make money in financial services?
Vanguard S&P Mid-Cap 400 Growth ETF generates revenue through management fees charged to investors. These fees are a percentage of the ETF's assets under management (AUM). The ETF's expense ratio is designed to be competitive, aligning with Vanguard's commitment to providing cost-effective investment solutions. The ETF's revenue is directly tied to its AUM, which is influenced by factors such as market performance, investor demand, and the ETF's ability to attract and retain assets. Vanguard's scale and efficiency help to minimize costs and maximize returns for investors.
What are the key factors to evaluate for IVOG?
Vanguard S&P Mid-Cap 400 Growth ETF (IVOG) currently holds an AI score of 47/100, indicating low score. Key strength: Low expense ratio. Primary risk to monitor: Ongoing: Market volatility can impact IVOG's performance, leading to potential losses for investors.. This is not financial advice.
How frequently does IVOG data refresh on this page?
IVOG prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven IVOG's recent stock price performance?
Recent price movement in Vanguard S&P Mid-Cap 400 Growth ETF (IVOG) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Low expense ratio. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- AI analysis pending for IVOG.
- Historical share price data has not been adjusted for the split except where market data is being used, as indicated. Although certain data may reflect both pre-and post-split prices, returns are not impacted.